Bardan I, Uhlig T, Sexton J, Kvien TK, Bakland G, Mielnik P, Hu Y, Molberg Ø, Aga AB, Kristianslund EK (2025)
Health-related Quality of Life in DMARD-treated adults with Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population
J Rheumatol (in press)
DOI 10.3899/jrheum.2025-0384, PubMed 40890003

Frid P, Halbig JM, Alstergren P, Berstad JR, Cetrelli L, Feuerherm AJ, Flatø B, Rosen A, Rosendahl K, Rygg M, Rypdal V, Songstad NT, Tømmerås B, Nordal E, Al-Haroni M (2025)
Cytokines in saliva, serum, and temporomandibular joint synovial fluid in children with juvenile idiopathic arthritis: An explorative cross-sectional study
Pediatr Rheumatol Online J, 23 (1), 66
DOI 10.1186/s12969-025-01118-y, PubMed 40528176

Hetland ML, Heiberg MS, Sokka-Isler T, Rudin A, Østergaard M, Haavardsholm E, Rutanen J, van Vollenhoven R, Grondal G, Ørnbjerg LM, Bøyesen P, Lampa J, Nurmohamed M, Gudbjornsson B, Uhlig T, Kononoff A, Lend K, Krabbe S, Olsen IC, Sexton J, Hørslev-Petersen K (2025)
Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm
Ann Rheum Dis, 84 (6), 937-948
DOI 10.1016/j.ard.2025.03.002, PubMed 40188008